Tauriga Sciences would like to thank all its loyal shareholders. The last few years have been difficult, primarily due negative consequences subsequent to the July 2015 PCAOB public censure of Tauriga’s former auditors, Cowan Gutenski. Tauriga Sciences settled the lawsuit against its former auditors in the 4th quarter of 2017 and there are several press releases detailing both the lawsuit and the settlement. Looking towards the future The Tauriga Sciences Board of Directors have taken advantage of several opportunities which could dramatically improve shareholder value and be valuable in negotiating any M&A. Please refer to the numerous press releases that the Company has put out regarding the the Company’s goal of a potential successful M&A.
New York, NY, Nov 29, 2018 (GLOBE NEWSWIRE via COMTEX) — New York, NY, Nov. 29, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Tauriga Sciences, Inc. (TAUG) (“Tauriga” or the “Company”), engaged in building its business through the development,
Tauriga Sciences (OTCPK:TAUG) has entered into a Memorandum of Understanding (“MOU”) to acquire a California based revenue generating OMEGA-3 product and technology. The MOU, executed on October 3, is valid for a period of 45 days.
Fully committed to commercializing innovation to enhance personal wellness, improve our environment and create lasting shareholder value.